Scaling Up Cell Therapy Manufacturing for Improved Access to Treatment

The speakers discuss Solaris, a company that has developed a fully automated cell-frame manufacturing platform called the Cell Shuttle. They emphasize the need to solve the manufacturing bottleneck in order to prevent patients from dying on waitlists. The chapter also covers Solaris' plans for expansion in Europe and Asia, their recent funding round, and the potential corporate partnership with global pharmaceutical company Bristol Myers Square.